Summary
Pfizer Inc. filed an 8-K on August 2, 2011, to report its financial results for the second quarter of 2011. The key details of these results are contained within a press release, filed as Exhibit 99 to this report. Investors should refer to this press release for the specific financial performance data, including revenue, earnings, and any forward-looking guidance provided by the company for the quarter ending June 30, 2011. While the 8-K itself does not provide the financial figures, it formally announces their release. This filing serves as the official notification to the market of Pfizer's quarterly performance, indicating that detailed information regarding its operational and financial condition for Q2 2011 is now publicly available through the attached press release. Investors are advised to consult Exhibit 99 for a comprehensive understanding of Pfizer's financial standing during this period.
Key Highlights
- 1Pfizer Inc. (PFE) announced its second quarter 2011 financial results on August 2, 2011.
- 2The 8-K filing serves as notification of the release of these Q2 2011 financial results.
- 3The detailed financial results are provided in a press release, filed as Exhibit 99.
- 4Exhibit 99 is incorporated by reference into the 8-K filing.
- 5Investors need to review Exhibit 99 for specific Q2 2011 financial performance data.
- 6The filing confirms the period covered is the second quarter of 2011.